×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| THEMIS MEDICARE LTD. | 948.28 | 5.19 | 938.06 | 0.06 | 1,609 | 34.9 |
| SYNCOM FORMULATIONS (INDIA) LT | 1315.7 | 130.02 | 1275.33 | 0.14 | 1598 | 40.8 |
| BLISS GVS PHARMA LTD. | 2256.83 | 258.03 | 2104.18 | 2.27 | 1482 | 17.5 |
Themis Medicare Ltd., with Security Code 530199, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 94.4 | 91.0 | 88.7 | 80.1 | 96.6 | 104.7 | 82.5 | 97.8 | 106.0 | 99.5 |
| Expenses | 74.1 | 69.7 | 73.5 | 69.6 | 74.9 | 92.4 | 74.4 | 88.5 | 76.8 | 82.6 |
| Operating Profit | 20.4 | 21.3 | 15.3 | 10.5 | 21.7 | 12.4 | 8.1 | 9.3 | 29.2 | 17.0 |
| OPM % | 21.56% | 23.45% | 17.2% | 13.09% | 22.5% | 11.84% | 9.78% | 9.52% | 27.57% | 17.09% |
| Other Income | 0.7 | 2.0 | 5.9 | 2.9 | 0.7 | 2.4 | 0.6 | 1.1 | 0.7 | 0.8 |
| Interest | 2.3 | 2.4 | 2.2 | 2.7 | 2.5 | 2.0 | 2.7 | 2.2 | 1.4 | 1.6 |
| Depreciation | 2.5 | 2.6 | 2.7 | 2.8 | 3.0 | 3.1 | 3.1 | 3.1 | 1.0 | 1.1 |
| Profit before tax | 16.3 | 18.4 | 16.3 | 7.9 | 16.9 | 9.7 | 2.9 | 5.2 | 27.5 | 15.1 |
| Tax % | 28.7% | 26.4% | 25.7% | 23.8% | 25.6% | 27.1% | 29.8% | 40.5% | 26.2% | 26.1% |
| Net Profit | 11.6 | 13.5 | 12.1 | 6.0 | 12.6 | 7.1 | 2.0 | 3.1 | 18.7 | 9.9 |
| EPS in Rs | 12.62 | 14.68 | 13.11 | 6.55 | 13.62 | 7.7 | 0.22 | 0.34 | 2.03 | 1.07 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 91.0 | 88.8 | 80.1 | 96.6 | 104.8 | 82.5 | 97.8 | 123.0 | 117.0 | 93.8 |
| Expenses | 69.7 | 73.5 | 69.6 | 74.9 | 92.4 | 74.5 | 88.5 | 93.8 | 99.9 | 87.8 |
| Operating Profit | 21.3 | 15.3 | 10.5 | 21.7 | 12.4 | 8.1 | 9.3 | 29.2 | 17.1 | 6.0 |
| OPM % | 23.5% | 17.2% | 13.1% | 22.5% | 11.8% | 9.8% | 9.5% | 23.7% | 14.6% | 6.4% |
| Other Income | 2.0 | 5.9 | 2.9 | 0.7 | 2.4 | 0.6 | 1.1 | 1.0 | 1.1 | 1.0 |
| Interest | 2.4 | 2.2 | 2.7 | 2.5 | 2.0 | 2.7 | 2.2 | 2.4 | 2.4 | 2.8 |
| Depreciation | 2.6 | 2.7 | 2.8 | 3.0 | 3.1 | 3.1 | 3.1 | 2.4 | 2.5 | 2.5 |
| Profit before tax | 18.4 | 16.3 | 7.9 | 16.9 | 9.7 | 2.8 | 5.2 | 25.4 | 13.4 | 1.7 |
| Tax % | 26.4% | 25.7% | 23.8% | 25.6% | 27.1% | 29.9% | 40.7% | 26.3% | 26.2% | 27% |
| Net Profit | 17.8 | 13.3 | 8.4 | 18.2 | 11.3 | 7.4 | 6.6 | 24.7 | 14.3 | 0.5 |
| EPS in Rs | 19 | 14 | 9 | 19 | 12 | 0 | 0 | 2 | 1 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 16% |
| 3 Years: | 18% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 32% |
| 3 Years: | -2% |
| TTM: | 70% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 33% |
| 3 Years: | 19% |
| 1 Year: | -26% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 16% |
| 3 Years: | 18% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 41% |
| 3 Years: | 6% |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 33% |
| 3 Years: | 19% |
| 1 Year: | -26% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|